Thymic Epithelial Tumours: Evaluation of Malignant Grade by Quantification of Proliferating Cell Nuclear Antigen and Nucleolar Organizer Regions

Overview

Journal Virchows Arch A Pathol Anat Histopathol

Specialty Anatomy & Histology

Date 1993 Jan 1

PMID 8099456

Citations 5

Authors

H Tateyama

T Mizuno

T Tada

T Eimoto

T Hashimoto

A Masaoka

Affiliations

Soon will be listed here.

Abstract

Cellular proliferation was studied by quantification of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer regions (AgNORs) of cells in 29 thymic epithelial tumours: 8 noninvasive (7 cortical and 1 mixed) thymomas, 11 invasive/metastatic (all cortical) thymomas, and 10 thymic carcinomas. Thymic carcinoma showed the highest percentage of cells positive for PCNA (14.73 +/- 5.419%) and the largest mean number of AgNORs per nucleus (4.89 +/- 0.756). The mean percentage of PCNA-positive cells and number of AgNORs in thymoma groups were as follows: in noninvasive thymoma 2.96 +/- 1.256% and 2.73 +/- 0.647, respectively, and in invasive/metastatic thymoma 4.41 +/- 1.823% and 3.68 +/- 1.148, respectively. The differences in PCNA and AgNORs were statistically significant between thymic carcinoma and each of thymoma groups. The overlap of the values between these tumours was minimal in the PCNA stains, although it was considerable in AgNOR counts as previously noted. However, there was no statistically significant difference in these markers between noninvasive and invasive/metastatic thymomas. These results indicate that thymoma in general is a slow-growing tumour compared with thymic carcinoma and that noninvasive thymoma is similar to invasive/metastatic thymoma with regard to proliferative activity; these latter two tumours may represent an essentially identical type in different stages of progression.

Citing Articles

Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.

Suster D, Miller J, Pihan G, Mackinnon A, Suster S Mod Pathol. 2021; 34(10):1831-1838.

PMID: 34135467 DOI: 10.1038/s41379-021-00839-1.

Clinicopathological analysis of small-sized thymoma with podoplanin and Ki 67 expression analysis.

Yokota K, Tateyama H, Yano M, Moriyama S, Hikosaka Y, Okuda K Mol Clin Oncol. 2014; 1(1):88-92.

PMID: 24649128 PMC: 3956257. DOI: 10.3892/mco.2012.2.

Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization.

Lee G, Yang W, Jeung H, Kim S, Seo M, Park C BMC Genomics. 2007; 8:305.

PMID: 17764580 PMC: 2082448. DOI: 10.1186/1471-2164-8-305.

Proliferative cell nuclear antigen expression in follicular tumours of the thyroid with special reference to oxyphilic cell lesions.

Tateyama H, Yang Y, Eimoto T, Tada T, Inagaki H, Nakamura T Virchows Arch. 1994; 424(5):533-7.

PMID: 7913369 DOI: 10.1007/BF00191440.

Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.

Gilhus N, Jones M, Turley H, Gatter K, Nagvekar N, Newsom-Davis J J Clin Pathol. 1995; 48(5):447-55.

PMID: 7629292 PMC: 502622. DOI: 10.1136/jcp.48.5.447.

References

Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet J . Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J. 1986; 18(1):5-14. DOI: 10.1007/BF01676192. View

Hsu S, RAINE L, FANGER H . Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981; 29(4):577-80. DOI: 10.1177/29.4.6166661. View

. The nucleolar organizer regions. Biol Cell. 1983; 49(3):191-202. View

Egan M, Crocker J . Nucleolar organiser regions in pathology. Br J Cancer. 1992; 65(1):1-7. PMC: 1977365. DOI: 10.1038/bjc.1992.1. View

Dervan P, Gilmartin L, Loftus B, Carney D . Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores. Am J Clin Pathol. 1989; 92(4):401-7. DOI: 10.1093/ajcp/92.4.401. View

Robbins B, de la Vega D, Ogata K, Tan E, Nakamura R . Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med. 1987; 111(9):841-5. View

Bravo R, Frank R, Blundell P . Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987; 326(6112):515-7. DOI: 10.1038/326515a0. View

Suster S, Rosai J . Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991; 67(4):1025-32. DOI: 10.1002/1097-0142(19910215)67:4<1025::aid-cncr2820670427>3.0.co;2-f. View

Hansen A, Ostergard B . Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue. Virchows Arch A Pathol Anat Histopathol. 1990; 417(1):9-13. DOI: 10.1007/BF01600103. View

10.

Ogata K, Kurki P, Celis J, Nakamura R, Tan E . Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res. 1987; 168(2):475-86. DOI: 10.1016/0014-4827(87)90020-6. View

11.

Waseem N, Lane D . Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci. 1990; 96 ( Pt 1):121-9. DOI: 10.1242/jcs.96.1.121. View

12.

Hartmann C, Roth C, Minck C, Niedobitek G . Thymic carcinoma. Report of five cases and review of the literature. J Cancer Res Clin Oncol. 1990; 116(1):69-82. DOI: 10.1007/BF01612643. View

13.

Garcia R, Coltrera M, Gown A . Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol. 1989; 134(4):733-9. PMC: 1879787. View

14.

Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G . Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer. 1986; 58(3):765-76. DOI: 10.1002/1097-0142(19860801)58:3<765::aid-cncr2820580326>3.0.co;2-s. View

15.

Levine G, Rosai J . Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol. 1978; 9(5):495-515. DOI: 10.1016/s0046-8177(78)80131-2. View

16.

Underwood J, Giri D . Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol. 1988; 155(2):95-6. DOI: 10.1002/path.1711550203. View

17.

Deschenes J, Weidner N . Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease. Am J Surg Pathol. 1990; 14(12):1148-55. DOI: 10.1097/00000478-199012000-00007. View

18.

Crocker J, Boldy D, Egan M . How should we count AgNORS? Proposals for a standardized approach. J Pathol. 1989; 158(3):185-8. DOI: 10.1002/path.1711580303. View

19.

Masaoka A, Monden Y, Nakahara K, Tanioka T . Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981; 48(11):2485-92. DOI: 10.1002/1097-0142(19811201)48:11<2485::aid-cncr2820481123>3.0.co;2-r. View

20.

Hall P, Levison D, Woods A, Yu C, Kellock D, Watkins J . Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990; 162(4):285-94. DOI: 10.1002/path.1711620403. View